France (FR)

TinyPols: a family of water-soluble binitroxides tailored for dynamic nuclear polarization enhanced NMR spectroscopy at 18.8 and 21.1 T (2020) Lund A, Casano G, Menzildjian G, Kaushik M, Stevanato G, Yulikov M, Jabbour R, et al. Journal article Effective dynamics from coherent state path integral of full loop quantum gravity (2020) Han M, Liu H Journal article Determination of the full deformation tensor by multi-Bragg fast scanning nano X-ray diffraction Determination of the full deformation tensor (2020) Johannes A, Rensberg J, Grunewald TA, Schoppe P, Ritzer M, Rosenthal M, Ronning C, Burghammer M Journal article Accumulation of positrons from a LINAC based source (2020) Niang S, Charlton M, Choi JJ, Chung M, Clade P, Comini P, Crivelli P, et al. Journal article Development of a PbWO4 detector for single-shot positron annihilation lifetime spectroscopy at the GBAR experiment (2020) Kim BH, Choi JJ, Chung M, Clade P, Comini P, Crivelli P, Crepin PP, et al. Journal article Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT (2020) Schmidt-Hieber M, Engelhard D, Ullmann A, Ljungman P, Maertens J, Martino R, Rovira M, et al. Journal article Neurobiological Divergence of the Positive and Negative Schizophrenia Subtypes Identified on a New Factor Structure of Psychopathology Using Non-negative Factorization: An International Machine Learning Study (2020) Chen J, Patil KR, Weis S, Sim K, Nickl-Jockschat T, Zhou J, Aleman A, et al. Journal article Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortar in haemodialysis patients from the AURORA trial (2020) Girerd S, Girerd N, Frimat L, Holdaas H, Jardine AG, Schmieder R, Fellstrom B, et al. Journal article A Randomized Phase II Study of Nivolumab Plus Ipilimumab Versus Standard of Care in Previously Untreated and Advanced Non-Clear Cell Renal Cell Carcinoma (Suniforecast) (2020) Ahrens M, Escudier B, Boleti E, Grimm MO, Goupir MG, Barthelemy P, Gravis G, et al. Conference contribution Phase III PAOLA-1/ENGOT-OV25 Trial: Olaparib Plus Bevacizumab (BEV) As Maintenance Therapy in Patients (PTS) with Newly Diagnosed, Advanced Ovarian Cancer (OC) Treated with Platinum-Based Chemotherapy (PCH) Plus Bev (2020) De Gregorio N, Harter P, Sehouli L, Canzler U, Marme F, Buderath P, Lueck HJ, et al. Conference contribution